Latest Content

10 of 504 Shown
  • Contemporary Management of HIV: Managing ART in HIV-Infected Patients With Common Comorbidities

    In this downloadable slideset, David A. Wohl, MD, and Program Director Joseph J. Eron, Jr., MD, review key data and offer expert guidance on managing HIV treatment in patients with frequently encountered comorbidities, including cardiovascular disease, osteopenia, and HCV coinfection.
    Date Posted: 7/19/2017
  • IAS 2017: A Preview of Key Data to Be Presented in Paris

    Anton L. Pozniak MD, FRCP - 7/17/2017
    Here is my take on the most anticipated studies that will be presented in Paris this year.
  • Contemporary Management of HIV: Antiretroviral Therapy as Prevention

    In this downloadable slideset, Kenneth Mayer, MD, and Program Director Joseph J. Eron, Jr., MD, review key data and optimal approaches for pre- and postexposure prophylaxis in patients at risk for HIV infection.

    Topics include:
    • HIV-uninfected MSM at risk for HIV infection
    • Heterosexual HIV-discordant couple
    • HIV-uninfected woman with substance use at risk for HIV infection
    • Practical considerations
    Date Posted: 6/28/2017
  • Weighing Boosted vs Unboosted Options for a Patient Who Requires Treatment Prior to Availability of Resistance Data

    Eric S. Daar MD - 6/21/2017 1 comment / Last Comment: 7/2/2017
    For a newly diagnosed patient with an OI and pending resistance test results, when and with what would you recommend initiating ART?
  • Optimizing ART for a Patient With PI Intolerance and a History of Resistance and Nonadherence

    Eric S. Daar MD - 6/21/2017 1 comment / Last Comment: 6/22/2017
    Would you switch a virologically suppressed patient who is experiencing PI toxicity to a PI-sparing regimen if they had a history of nonadherence and resistance?
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Contemporary Management of HIV: To Boost or Not to Boost: Advantages and Disadvantages of Boosted ART

    In this downloadable slideset, Eric S. Daar, MD, and Program Director Joseph J. Eron, Jr., MD, review advantages and disadvantages of boosted ART regimens for managing patients with HIV.
    Date Posted: 6/16/2017
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017 1 comment / Last Comment: 6/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017 2 comments / Last Comment: 7/2/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • Adopting Lung Cancer Screening Recommendations for an HIV-Infected Individual With a Smoking History

    David A. Wohl MD - 5/31/2017
    What qualifies an HIV-infected past or current smoker for annual lung cancer screening using low-dose CT scans?
10 of 504 Shown
Show 10 More
Decision Support
Immediate answers to treatment questions
More than just up to date